[Mindray Announces Third Quarter 2010 Financial Results Shenzhen, China November 8, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter and nine months ended September 30, 2010. Highlights for 2010 Third Quarter and Nine Months Third quarter 2010]
[Mindray Announces Third Quarter 2010 Financial Results Shenzhen, China November 8, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter and nine months ended September 30, 2010. Highlights for 2010 Third Quarter and Nine Months Third quarter 2010]
[EXECUTION VERSION 8,050,000 SHARES CHINA CORD BLOOD CORPORATION ORDINARY SHARES, PAR VALUE US$0.0001 PER SHARE UNDERWRITING AGREEMENT November 5, 2010 November 5, 2010 Jefferies & Company, Inc. 520 Madison Avenue New York, NY 10022 Ladies and Gentlemen: Company “Underwriter”) “Selling Shareholders” Firm Shares Schedule I China Cord Blood Corporation, an exempted company with limited liability registered by way of continuation] [China Cord Blood Corporation Announces Pricing of Follow-On Public Offering of Ordinary Shares 5 s HONG KONG, China, November The Company intends to use the net proceeds it will receive from the Offering to establish a new storage facility in Zhejiang province, to develop the Zhejiang operation and for general working capital purposes. The Company will not receive any of]
[EXECUTION VERSION 8,050,000 SHARES CHINA CORD BLOOD CORPORATION ORDINARY SHARES, PAR VALUE US$0.0001 PER SHARE UNDERWRITING AGREEMENT November 5, 2010 November 5, 2010 Jefferies & Company, Inc. 520 Madison Avenue New York, NY 10022 Ladies and Gentlemen: Company “Underwriter”) “Selling Shareholders” Firm Shares Schedule I China Cord Blood Corporation, an exempted company with limited liability registered by way of continuation] [China Cord Blood Corporation Announces Pricing of Follow-On Public Offering of Ordinary Shares 5 s HONG KONG, China, November The Company intends to use the net proceeds it will receive from the Offering to establish a new storage facility in Zhejiang province, to develop the Zhejiang operation and for general working capital purposes. The Company will not receive any of]
[TABLE OF CONTENTS] [CERTIFICATION I, Jack Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of UTStarcom, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [CERTIFICATION I, Edmond Cheng, certify that: 1. I have reviewed this quarterly report on Form 10-Q of UTStarcom, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES OXLEY ACT OF 2002 (i) (ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 8, 2010 EX-32.1 4 a10-17289_1ex32d1.htm EX-32.1]
[Mindray Announces Third Quarter 2010 Financial Results Shenzhen, China November8, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter and nine months ended September30, 2010. Highlights for 2010 Third Quarter and Nine Months]
[Mindray Announces Third Quarter 2010 Financial Results Shenzhen, China November8, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter and nine months ended September30, 2010. Highlights for 2010 Third Quarter and Nine Months]
[THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred (a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 525) CONTINUING CONNECTED TRANSACTIONS Independent financial adviser to A letter from the Board is set out on pages 5 to 12 of this circular. A] [(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 525) NOTICE OF EXTRAORDINARY GENERAL MEETING NOTICE IS HEREBY GIVEN THAT Extraordinary General Meeting Company PRC ORDINARY RESOLUTION 1. THAT Framework Comprehensive Services Agreement Notes: (1) Holders of the H shares of the Company are advised that the register of members of the Companys H] [TABLE OF CONTENTS EX-99.1 EX-99.2 Number Description of Document 99.1 Continuing Connected Transactions Circular, dated November 5, 2010 99.2 Notice of Extraordinary General Meeting, dated November 5, 2010 2 Guangshen Railway Company Limited Dated: November 8, 2010]
[Himax Reports Third Quarter 2010 Financial Results Expects Fourth Quarter 2010 Revenue to be Approximately Flat Sequentially TAINAN, Taiwan, Nov. 8, 2010 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. ("Himax" or "Company") (Nasdaq:HIMX) today reported financial results for the third quarter ended September 30, 2010. For the third quarter of 2010, Himax reported net revenues of $138.3 million, representing a 31.9%] [FORM 6-K November 2010 000-51847 Himax Technologies, Inc. No.26, Zih Lian Road, Fonghua Village, Note: Note: Himax Technologies, Inc. Chief Financial Officer 6-K 1 f6k_110810.htm FORM 6-K]
